U.S. official raises concerns over Zika readiness
The ability of the United States to respond to a potential spike in Zika virus infection rates is a cause for concern, according to a top federal health official.
“The big question is will we get... (Source: Rheumatology News)
Source: Rheumatology News - May 4, 2016 Category: Rheumatology Source Type: research
Remicade to infliximab biosimilar switches fare well in real-life practice
GLASGOW – Switching patients on the anti–tumor necrosis factor drug Remicade to a biosimilar infliximab product resulted in good efficacy and tolerability with substantial cost savings in two... (Source: Rheumatology News)
Source: Rheumatology News - May 3, 2016 Category: Rheumatology Source Type: research
One-time AMH level predicts rapid perimenopausal bone loss
BOSTON – Anti-Müllerian hormone levels strongly predict the rate of perimenopausal loss of bone mineral density and might help identify women who need early intervention to prevent future... (Source: Rheumatology News)
Source: Rheumatology News - May 2, 2016 Category: Rheumatology Source Type: research
A dermatologist’s skin tips for rheumatologists
MAUI, HAWAII – Before concluding that a patient’s erythematous facial butterfly rash is an open and shut case of acute cutaneous lupus erythematosus, consider this, Dr. George M. Martin advised:... (Source: Rheumatology News)
Source: Rheumatology News - May 1, 2016 Category: Rheumatology Source Type: research
Kawasaki disease and infections aren’t mutually exclusive
CHICAGO – Kawasaki disease and concurrent bacterial or viral infection are by no means mutually exclusive, Dr. Cathie-Kim Le cautioned at the annual meeting of the American College of Cardiology.... (Source: Rheumatology News)
Source: Rheumatology News - May 1, 2016 Category: Rheumatology Source Type: research
Risk of arthritis in children with Down syndrome higher than previously reported
GLASGOW – Children with Down syndrome are at increased risk for arthritis that often goes unrecognized and leads to treatment delays and potential chronic disability.
Research presented at the... (Source: Rheumatology News)
Source: Rheumatology News - April 30, 2016 Category: Rheumatology Source Type: research
Supreme Court case could expand false claims liability
A case before the U.S. Supreme Court that could expand physicians’ liability under the False Claims Act (FCA).
The case of <a... (Source: Rheumatology News)
Source: Rheumatology News - April 29, 2016 Category: Rheumatology Source Type: research
Long-term use of opioids for musculoskeletal pain incurs major risks
GLASGOW, SCOTLAND – Adverse events ranging from major trauma to osteoporosis to death from any cause occurred at significantly higher rates among people who were prescribed opioids long term for... (Source: Rheumatology News)
Source: Rheumatology News - April 29, 2016 Category: Rheumatology Source Type: research
Effective psoriasis therapy may reduce coronary plaque burden
CHICAGO – Improvement in psoriasis was associated with a significant reduction in coronary plaque burden within 1 year in a pilot study conducted at the National Heart, Lung, and Blood Institute,... (Source: Rheumatology News)
Source: Rheumatology News - April 28, 2016 Category: Rheumatology Source Type: research
Opioid reform legislation passes House committee
The House Energy & Commerce Committee has passed a comprehensive package of bills designed to curb the nation’s opioid epidemic.
Eleven opioid-related bills passed the full committee by voice... (Source: Rheumatology News)
Source: Rheumatology News - April 28, 2016 Category: Rheumatology Source Type: research
CMS promises streamlined, flexible program to replace meaningful use
Meaningful use would get a new name and an emphasis on flexibility under a proposal from the Centers for Medicare & Medicaid Services.
“We’re proposing today to replace meaningful use in the... (Source: Rheumatology News)
Source: Rheumatology News - April 28, 2016 Category: Rheumatology Source Type: research
Secukinumab improves patient-reported outcomes in ankylosing spondylitis
GLASGOW, SCOTLAND – Treatment with the anti–interleukin-17A monoclonal antibody secukinumab improved a range of patient-reported outcome measures in a phase III trial of patients with ankylosing... (Source: Rheumatology News)
Source: Rheumatology News - April 27, 2016 Category: Rheumatology Source Type: research
Superhigh ferritin spells trouble in macrophage activation syndrome
MAUI, HAWAII – The use of new classification criteria for macrophage activation syndrome specific to systemic juvenile idiopathic arthritis will help to avoid missing patients with the criteria that... (Source: Rheumatology News)
Source: Rheumatology News - April 26, 2016 Category: Rheumatology Source Type: research
After Inflectra’s approval, challenges remain for biosimilars
Now that the Food and Drug Administration has approved Inflectra as the first biosimilar version of the anti–tumor necrosis factor-alpha agent Remicade, rheumatologists and patient advocacy groups... (Source: Rheumatology News)
Source: Rheumatology News - April 26, 2016 Category: Rheumatology Source Type: research
Imaging can predict who’ll progress from nonspecific symptoms to arthritis
MAUI, HAWAII – Recent evidence indicates that subclinical joint inflammation on ultrasound or MRI in patients having a positive cyclic citrullinated peptide antibody test but only nonspecific... (Source: Rheumatology News)
Source: Rheumatology News - April 26, 2016 Category: Rheumatology Source Type: research
